135 related articles for article (PubMed ID: 3958905)
1. Pharmacokinetics of orally administered pentoxifylline in humans.
Smith RV; Waller ES; Doluisio JT; Bauza MT; Puri SK; Ho I; Lassman HB
J Pharm Sci; 1986 Jan; 75(1):47-52. PubMed ID: 3958905
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and pharmacokinetics of 14C-pentoxifylline in healthy volunteers.
Bryce TA; Chamberlain J; Hillbeck D; Macdonald CM
Arzneimittelforschung; 1989 Apr; 39(4):512-7. PubMed ID: 2751739
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of intravenous and oral pentoxifylline in healthy subjects.
Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A
Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.
Rames A; Poirier JM; LeCoz F; Midavaine M; Lecocq B; Grange JD; Poupon R; Cheymol G; Jaillon P
Clin Pharmacol Ther; 1990 Mar; 47(3):354-9. PubMed ID: 2178853
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
Kwong EC; Chen FC; Young LM
Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline in end-stage renal disease.
Silver MR; Kroboth PD
Drug Intell Clin Pharm; 1987 Dec; 21(12):976-8. PubMed ID: 3428162
[TBL] [Abstract][Full Text] [Related]
7. Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk.
Bauza MT; Smith RV; Knutson DE; Witter FR
J Chromatogr; 1984 Sep; 310(1):61-9. PubMed ID: 6501523
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
Raz I; Ben-David J; Hussein Z; Samara E
Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
[TBL] [Abstract][Full Text] [Related]
9. Alteration of pentoxifylline pharmacokinetics by cimetidine.
Mauro VF; Mauro LS; Hageman JH
J Clin Pharmacol; 1988 Jul; 28(7):649-54. PubMed ID: 3216031
[TBL] [Abstract][Full Text] [Related]
10. The excretion of pentoxifylline and its metabolites into human breast milk.
Witter FR; Smith RV
Am J Obstet Gynecol; 1985 Apr; 151(8):1094-7. PubMed ID: 3985069
[TBL] [Abstract][Full Text] [Related]
11. Determination of oxpentifylline and four metabolites in plasma and urine by automated capillary gas chromatography using nitrogen-selective detection.
Burrows JL; Jolley KW
J Chromatogr; 1985 Nov; 344():187-98. PubMed ID: 4086540
[TBL] [Abstract][Full Text] [Related]
12. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography.
Bryce TA; Burrows JL; Jolley KW
J Chromatogr; 1985 Nov; 344():397-402. PubMed ID: 4086565
[No Abstract] [Full Text] [Related]
13. Pentoxifylline: a new agent for intermittent claudication.
Baker DE; Campbell RK
Drug Intell Clin Pharm; 1985 May; 19(5):345-8. PubMed ID: 3891279
[TBL] [Abstract][Full Text] [Related]
14. Microbial models of mammalian metabolism: microbial reduction and oxidation of pentoxifylline.
Davis PJ; Yang SK; Smith RV
Appl Environ Microbiol; 1984 Aug; 48(2):327-31. PubMed ID: 6486781
[TBL] [Abstract][Full Text] [Related]
15. [Investigations on the pharmacokinetics of pentoxifylline in chronic renal failure (authors transl)].
Schaefer K; von Herrath D; Hensel A; Grigoleit HG
Med Klin; 1977 Feb; 72(6):204-6. PubMed ID: 840136
[TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency.
Paap CM; Simpson KS; Horton MW; Schaefer KL; Lassman HB; Sack MR
Ann Pharmacother; 1996; 30(7-8):724-9. PubMed ID: 8826548
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of pentoxifylline clearance by cimetidine.
Luke DR; Rocci ML; Hoholick C
J Pharm Sci; 1986 Feb; 75(2):155-7. PubMed ID: 3958924
[TBL] [Abstract][Full Text] [Related]
18. Determination of pentoxifylline and its major metabolites in microbial extracts by thin-layer and high-performance liquid chromatography.
Smith RV; Yang SK; Davis PJ; Bauza MT
J Chromatogr; 1983 Dec; 281():281-7. PubMed ID: 6668334
[TBL] [Abstract][Full Text] [Related]
19. Administration of crushed extended-release pentoxifylline tablets: bioavailability and adverse effects.
Cleary JD; Evans PC; Hikal AH; Chapman SW
Am J Health Syst Pharm; 1999 Aug; 56(15):1529-34. PubMed ID: 10478991
[TBL] [Abstract][Full Text] [Related]
20. Determination of oxpentifylline and three metabolites in plasma by automated capillary gas chromatography using nitrogen-selective detection.
Burrows JL
J Chromatogr; 1987 Dec; 423():139-46. PubMed ID: 3443643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
